Tuning of protein kinase circuitry by p38α is vital for epithelial tissue homeostasis

Journal of Biological Chemistry

Volumn 288, Issue 33, 2013, Pages 23788-23797

  Caballero Franco, Celia ^a   Choo, Min Kyung ^a   Sano, Yasuyo ^a   Ritprajak, Patcharee ^a,b   Sakurai, Hiroaki ^c   Otsu, Kinya ^d,e   Mizoguchi, Atsushi ^a   Park, Jin Mo ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c UNIVERSITY OF TOYAMA   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS; TISSUE HOMEOSTASIS;

ADVERSE EFFECT; CELLULAR RESPONSE; EPITHELIAL CELLS; PROTEIN KINASE;

ENZYMES;

EPIDERMAL GROWTH FACTOR RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME LOCALIZATION; EPITHELIUM; HOMEOSTASIS; INTESTINE CELL; INTESTINE EPITHELIUM; KERATINOCYTE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TRANSPORT; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; TISSUE CHARACTERIZATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; APOPTOSIS; C57BL MOUSE; ENZYMOLOGY; EPITHELIUM CELL; HUMAN; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; SKIN; UBIQUITINATION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; EPITHELIAL CELLS; EPITHELIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HOMEOSTASIS; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SKIN; UBIQUITINATION;

EID: 84882420839     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.452029     Document Type: Article

References (50)

1. Chang, L., and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40
2. Johnson, G. L., and Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912
3. Dong, C., Davis, R. J., and Flavell, R. A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72
4. Simons, B. D., and Clevers, H. (2011) Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 145, 851-862
5. Hsu, Y. C., and Fuchs, E. (2012) A family business: stem cell progeny join the niche to regulate homeostasis. Nat. Rev. Mol. Cell Biol. 13, 103-114
6. Vereecke, L., Beyaert, R., and van Loo, G. (2011) Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol. Med. 17, 584-593
7. Kubo, A., Nagao, K., and Amagai, M. (2012) Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 122, 440-447
8. Medema, J. P., and Vermeulen, L. (2011) Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 474, 318-326
9. Dotto, G. P. (2008) Notch tumor suppressor function. Oncogene 27, 5115-5123
10. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., and Landvatter, S. W. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746
11. Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811
12. Tamura, K., Sudo, T., Senftleben, U., Dadak, A. M., Johnson, R., and Karin, M. (2000) Requirement for p38 in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102, 221-231
13. Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R., and Nebreda, A. R. (2000) Essential role of p38 MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6, 109-116
14. Allen, M., Svensson, L., Roach, M., Hambor, J., McNeish, J., and Gabel, C. A. (2000) Deficiency of the stress kinase p38 results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191, 859-870
15. Mudgett, J. S., Ding, J., Guh-Siesel, L., Chartrain, N. A., Yang, L., Gopal, S., and Shen, M. M. (2000) Essential role for p38 mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 97, 10454-10459
16. Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H., and Wagner, E. F. (2007) p38 suppresses normal and cancer cell proliferation by antagonizing the JNKc-Jun pathway. Nat. Genet. 39, 741-749
17. Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M., and Nebreda, A. R. (2007) p38 MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39, 750-758
18. Nishida, K., Yamaguchi, O., Hirotani, S., Hikoso, S., Higuchi, Y., Watanabe, T., Takeda, T., Osuka, S., Morita, T., Kondoh, G., Uno, Y., Kashiwase, K., Taniike, M., Nakai, A., Matsumura, Y., Miyazaki, J., Sudo, T., Hongo, K., Kusakari, Y., Kurihara, S., Chien, K. R., Takeda, J., Hori, M., and Otsu, K. (2004) p38+ mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol. Cell. Biol. 24, 10611-10620
19. Kim, C., Sano, Y., Todorova, K., Carlson, B. A., Arpa, L., Celada, A., Lawrence, T., Otsu, K., Brissette, J. L., Arthur, J. S., and Park, J. M. (2008) The kinase p38+ serves cell type-specific inflammatory functions in skin injury and coordinates pro-and anti-inflammatory gene expression. Nat. Immunol. 9, 1019-1027
20. Huang, G., Wang, Y., Vogel, P., Kanneganti, T. D., Otsu, K., and Chi, H. (2012) Signaling via the kinase p38+ programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat. Immunol. 13, 152-161
21. Otsuka, M., Kang, Y. J., Ren, J., Jiang, H., Wang, Y., Omata, M., and Han, J. (2010) Distinct effects of p38+ deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology 138, 1255-1265
22. Heinrichsdorff, J., Luedde, T., Perdiguero, E., Nebreda, A. R., and Pasparakis, M. (2008) p38+ MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin-induced liver failure.EMBORep. 9, 1048-1054
23. Guma, M., Hammaker, D., Topolewski, K., Corr, M., Boyle, D. L., Karin, M., and Firestein, G. S. (2012) Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6. Arthritis Rheum. 64, 2887-2895
24. Kang, Y. J., Chen, J., Otsuka, M., Mols, J., Ren, S., Wang, Y., and Han, J. (2008) Macrophage deletion of p38+ partially impairs lipopolysaccharideinduced cellular activation. J. Immunol. 180, 5075-5082
25. Cohen, S. B., Cheng, T. T., Chindalore, V., Damjanov, N., Burgos-Vargas, R., Delora, P., Zimany, K., Travers, H., and Caulfield, J. P. (2009) Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis Rheum. 60, 335-344
26. Damjanov, N., Kauffman, R. S., and Spencer-Green, G. T. (2009) Efficacy, pharmacodynamics, and safety of VX-702, a novel p38MAPKinhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies. Arthritis Rheum. 60, 1232-1241
27. Genovese, M. C., Cohen, S. B., Wofsy, D., Weinblatt, M. E., Firestein, G. S., Brahn, E., Strand, V., Baker, D. G., and Tong, S. E. (2011)A24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis. J. Rheumatol. 38, 846-854
28. Ritprajak, P., Hayakawa, M., Sano, Y., Otsu, K., and Park, J. M. (2012) Cell type-specific targeting dissociates the therapeutic from the adverse effects of protein kinase inhibition in allergic skin disease. Proc. Natl. Acad. Sci. U.S.A. 109, 9089-9094
29. Madison, B. B., Dunbar, L., Qiao, X. T., Braunstein, K., Braunstein, E., and Gumucio, D. L. (2002) Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277, 33275-33283
30. Vidal, K., Grosjean, I., evillard, J. P., Gespach, C., and Kaiserlian, D. (1993) Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. J. Immunol. Methods 166, 63-73
31. Singhirunnusorn, P., Suzuki, S., Kawasaki, N., Saiki, I., and Sakurai, H. (2005) Critical roles of threonine 187 phosphorylation in cellular stressinduced rapid and transient activation of transforming growth factor-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J. Biol. Chem. 280, 7359-7368
32. Greenblatt, M. B., Shim, J. H., Zou, W., Sitara, D., Schweitzer, M., Hu, D., Lotinun, S., Sano, Y., Baron, R., Park, J. M., Arthur, S., Xie, M., Schneider, M. D., Zhai, B., Gygi, S., Davis, R., and Glimcher, L. H. (2010) The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J. Clin. Invest. 120, 2457-2473
33. Askari, N., Diskin, R., Avitzour, M., Capone, R., Livnah, O., and Engelberg, D. (2007) Hyperactive variants of p38+ induce, whereas hyperactive variants of p38+ suppress, activating protein 1-mediated transcription. J. Biol. Chem. 282, 91-99
34. Park, J. M., Ng, V. H., Maeda, S., Rest, R. F., and Karin, M. (2004) AnthrolysinOand other gram-positive cytolysins are toll-like receptor 4 agonists. J. Exp. Med. 200, 1647-1655
35. Javelaud, D., and Besançon, F. (2001) NFκB activation results in rapid inactivation of JNK in TNF-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NFκB. Oncogene 20, 4365-4372
36. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., and Franzoso, G. (2001) Induction of gadd45 by NFκB downregulates pro-apoptotic JNK signalling. Nature 414, 308-313
37. Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., and Lin, A. (2001) Inhibition of JNK activation through NFκB target genes. Nature 414, 313-317
38. Zhang, J. Y., Green, C. L., Tao, S., and Khavari, P. A. (2004) NFκB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 18, 17-22
39. Maeda, S., Kamata, H., Luo, J. L., Leffert, H., and Karin, M. (2005) IKK couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977-990
40. Wong, V. W., Stange, D. E., Page, M. E., Buczacki, S., Wabik, A., Itami, S., van de Wetering, M., Poulsom, R., Wright, N. A., Trotter, M. W., Watt, F. M., Winton, D. J., Clevers, H., and Jensen, K. B. (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat. Cell Biol. 14, 401-408
41. Biteau, B., and Jasper, H. (2011) EGF signaling regulates the proliferation of intestinal stem cells in Drosophila. Development 138, 1045-1055
42. Jiang, H., Grenley, M. O., Bravo, M. J., Blumhagen, R. Z., and Edgar, B. A. (2011) EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila. Cell Stem Cell 8, 84-95
43. Frey, M. R., Dise, R. S., Edelblum, K. L., and Polk, D. B. (2006) p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J. 25, 5683-5692
44. Swat, A., Dolado, I., Rojas, J. M., and Nebreda, A. R. (2009) Cell densitydependent inhibition of epidermal growth factor receptor signaling by p38+ mitogen-activated protein kinase via Sprouty2 downregulation. Mol. Cell. Biol. 29, 3332-3343
45. Zwang, Y., and Yarden, Y. (2006) p38MAPkinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J. 25, 4195-4206
46. Singhirunnusorn, P., Ueno, Y., Matsuo, M., Suzuki, S., Saiki, I., and Sakurai, H. (2007) Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-through the TAK1-p38 signaling pathway. J. Biol. Chem. 282, 12698-12706
47. Deng, Y., Ren, X., Yang, L., Lin, Y., and Wu, X. (2003) A JNK-dependent pathway is required for TNF-induced apoptosis. Cell 115, 61-70
48. Sakurai, H. (2012) Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 33, 522-530
49. Mbalaviele, G., Anderson, G., Jones, A., De Ciechi, P., Settle, S., Mnich, S., Thiede, M., Abu-Amer, Y., Portanova, J., and Monahan, J. (2006) Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction. J. Pharmacol. Exp. Ther. 317, 1044-1053
50. Cheung, P. C., Campbell, D. G., Nebreda, A. R., and Cohen, P. (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38+. EMBO J. 22, 5793-5805